Browse by Journal Title

Article

Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
Simonetti, G. and Padella, A. and do Valle, I.F. and Fontana, M.C. and Fonzi, E. and Bruno, S. and Baldazzi, C. and Guadagnuolo, V. and Manfrini, M. and Ferrari, A. and Paolini, S. and Papayannidis, C. and Marconi, G. and Franchini, E. and Zuffa, E. and Laginestra, M.A. and Zanotti, F. and Astolfi, A. and Iacobucci, I. and Bernardi, S. and Sazzini, M. and Ficarra, E. and Hernandez, J.M. and Vandenberghe, P. and Cools, J. and Bullinger, L. and Ottaviani, E. and Testoni, N. and Cavo, M. and Haferlach, T. and Castellani, G. and Remondini, D. and Martinelli, G.
Cancer 125 (5): 712-725. 1 March 2019

Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
Busse, A. and Kraus, M. and Na, I.K. and Rietz, A. and Scheibenbogen, C. and Driessen, C. and Blau, I.W. and Thiel, E. and Keilholz, U.
Cancer 112 (3): 659-670. 1 February 2008

Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation.
Schmitz, N. and Kloess, M. and Reiser, M. and Berdel, W.E. and Metzner, B. and Doerken, B. and Kneba, M. and Trumper, L. and Loeffler, M. and Pfreundschuh, M. and Glass, B.
Cancer 106 : 136-145. 1 January 2006

31phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors.
Kettelhack, C. and Wickede, M.V. and Vogl, T. and Schneider, U. and Hohenberger, P.
Cancer 94 : 1557-1564. 1 January 2002

Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus, S.E. and Zirbes, T.K. and Hanisch, F.G. and Kunze, D. and Shafizadeh, S.T. and Nolden, S. and Moenig, S.P. and Schneider, P.M. and Karsten, U. and Thiele, J. and Hoelscher, A.H. and Dienes, H.P.
Cancer 88 (7): 1536-1543. 1 April 2000

Results of surgery and multimodal therapy for patients with soft tissue sarcoma invading to vascular structures.
Hohenberger, P. and Allenberg, J.R. and Schlag, P.M. and Reichardt, P.
Cancer 85 : 396-408. 15 January 1999

Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus, S.E. and Hanisch, F.G. and Kotlarek, G.M. and Zirbes, T.K. and Thiele, J. and Isenberg, J. and Karsten, U. and Devine, P.L. and Dienes, H.P.
Cancer 82 : 1019-1027. 1 January 1998

Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation.
Cao, Y. and Karsten, U. and Liebrich, W. and Haensch, W. and Springer, G.F. and Schlag, P.M.
Cancer 76 : 1700-1708. 1 January 1995

Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study.
Maschmeyer, G. and Link, H. and Hiddemann, W. and Meyer, P. and Helmerking, M. and Eisenmann, E. and Schmitt, J. and Adam, D.
Cancer 73 (9): 2296-2304. 1 May 1994

Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.
Kiechle-Schwarz, M. and Bauknecht, T. and Wienker, T.F. and Walz, L. and Pfleiderer, A.
Cancer 72 : 2423-2432. 1 January 1993

Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
Schoeber, C. and Papageorgiou, E. and Harstrick, A. and Bokemeyer, C. and Mugge, A. and Stahl, M. and Wilke, H. and Poliwoda, H. and Hiddemann, W. and Koehne-Woempner, C. and Weiss, J. and Preiss, J. and Schmoll, H.J.
Cancer 72 : 2242-2247. 1 January 1993

Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Freund, M. and Diedrich, H. and Ganser, A. and Gramatzki, M. and Heil, G. and Heyll, A. and Henke, M. and Hiddemann, W. and Haas, R. and Kuse, R. and Koch, P. and Link, H. and Maschmeyer, G. and Planker, M. and Queisser, W. and Schadeck-Gressel, C. and Schmitz, N. and von Verschuer, U. and Wilhelm, S. and Thiel, E. and Hoelzer, D.
Cancer 69 : 709-716. 1 January 1992

Regional administration of lymphokine-activated killer cells can be superior to intravenous application.
Keilholz, U. and Schlag, P.M. and Tilgen, W. and Brado, B. and Galm, F. and Goerich, J. and Kauffmann, G.W. and Moeller, P. and Schneider, S. and Hunstein, W.
Cancer 69 : 2172-2175. 1 January 1992